|
|
||||||||
Journal of General Virology, Vol 79, 1445-1452, Copyright © 1998 by Society for General Microbiology
ARTICLES |
L Szekely, F Chen, N Teramoto, B Ehlin-Henriksson, K Pokrovskaja, A Szeles, A Manneborg-Sandlund, M Lowbeer, ET Lennette and G Klein
Microbiology and Tumour Biology Centre, Karolinska Institute, Stockholm, Sweden. lassze@ki.se
A body cavity lymphoma-derived cell line (BC1), known to carry both Epstein-Barr virus (EBV) and human herpes virus type 8 (HHV-8; or Kaposi's sarcoma-associated herpesvirus, KSHV), was analysed for the expression of EBV-encoded, growth transformation-associated antigens and cellular phenotype by immunofluorescence staining, Western blotting, RT-PCR and flow cytometry. A similar phenotypic analysis was also performed on another body cavity lymphoma line, BCBL1, that is singly infected with HHV-8. Phenotypically, the two lines were closely similar. Although both lines are known to carry rearranged immunoglobulin genes, they were mostly negative for B-cell surface markers. Both expressed the HHV-8-encoded nuclear antigen (LNA1). Similarly to Epstein-Barr nuclear antigen type 1 (EBNA1), LNA1 was associated with the chromatin in interphase nuclei and the mitotic chromosomes in metaphase. It accumulated in a few well-circumscribed nuclear bodies that did not co-localize with EBNA1. BC1 cells expressed EBNA1, LMP2A and EBV-encoded small RNAs but not EBNA2-6, LMP1 and LMP2B. They were thus similar to type I Burkitt's lymphoma cells and latently infected peripheral B-cells. Analysis of the splicing pattern of the EBNA1-encoding message by RT-PCR showed that BC1 cells used the QUK but not the YUK splice, indicating that the mRNA was initiated from Qp and not from Cp or Wp.
This article has been cited by other articles:
![]() |
G. Fejer, A. Koroknai, F. Banati, I. Gyory, D. Salamon, H. Wolf, H. H. Niller, and J. Minarovits Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus J. Gen. Virol., June 1, 2008; 89(6): 1364 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-Q Du, C M Bacon, and P G Isaacson Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders J. Clin. Pathol., December 1, 2007; 60(12): 1350 - 1357. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. You, V. Srinivasan, G. V. Denis, W. J. Harrington Jr., M. E. Ballestas, K. M. Kaye, and P. M. Howley Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Interacts with Bromodomain Protein Brd4 on Host Mitotic Chromosomes. J. Virol., September 1, 2006; 80(18): 8909 - 8919. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fan, D. Bubman, A. Chadburn, W. J. Harrington Jr., E. Cesarman, and D. M. Knowles Distinct Subsets of Primary Effusion Lymphoma Can Be Identified Based on Their Cellular Gene Expression Profile and Viral Association J. Virol., January 15, 2005; 79(2): 1244 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Barbera, M. E. Ballestas, and K. M. Kaye The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 N Terminus Is Essential for Chromosome Association, DNA Replication, and Episome Persistence J. Virol., January 1, 2004; 78(1): 294 - 301. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Trivedi, K. Takazawa, C. Zompetta, L. Cuomo, E. Anastasiadou, A. Carbone, S. Uccini, F. Belardelli, K. Takada, L. Frati, et al. Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expression Blood, January 1, 2004; 103(1): 313 - 316. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Martinez-Guzman, T. Rickabaugh, T.-T. Wu, H. Brown, S. Cole, M. J. Song, L. Tong, and R. Sun Transcription Program of Murine Gammaherpesvirus 68 J. Virol., October 1, 2003; 77(19): 10488 - 10503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Viejo-Borbolla, E. Kati, J. A. Sheldon, K. Nathan, K. Mattsson, L. Szekely, and T. F. Schulz A Domain in the C-Terminal Region of Latency-Associated Nuclear Antigen 1 of Kaposi's Sarcoma-Associated Herpesvirus Affects Transcriptional Activation and Binding to Nuclear Heterochromatin J. Virol., June 15, 2003; 77(12): 7093 - 7100. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. V. Ablashi, L. G. Chatlynne, J. E. Whitman Jr., and E. Cesarman Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases Clin. Microbiol. Rev., July 1, 2002; 15(3): 439 - 464. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mattsson, C. Kiss, G. M. Platt, G. R. Simpson, E. Kashuba, G. Klein, T. F. Schulz, and L. Szekely Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions J. Gen. Virol., January 1, 2002; 83(1): 179 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Groves, M. A. Cotter, C. Subramanian, and E. S. Robertson The Latency-Associated Nuclear Antigen Encoded by Kaposi's Sarcoma-Associated Herpesvirus Activates Two Major Essential Epstein-Barr Virus Latent Promoters J. Virol., October 1, 2001; 75(19): 9446 - 9457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Piolot, M. Tramier, M. Coppey, J.-C. Nicolas, and V. Marechal Close but Distinct Regions of Human Herpesvirus 8 Latency-Associated Nuclear Antigen 1 Are Responsible for Nuclear Targeting and Binding to Human Mitotic Chromosomes J. Virol., April 15, 2001; 75(8): 3948 - 3959. [Abstract] [Full Text] |
||||
![]() |
M. E. Ballestas and K. M. Kaye Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen 1 Mediates Episome Persistence through cis-Acting Terminal Repeat (TR) Sequence and Specifically Binds TR DNA J. Virol., April 1, 2001; 75(7): 3250 - 3258. [Abstract] [Full Text] |
||||
![]() |
J. S. Cannon, D. Ciufo, A. L. Hawkins, C. A. Griffin, M. J. Borowitz, G. S. Hayward, and R. F. Ambinder A New Primary Effusion Lymphoma-Derived Cell Line Yields a Highly Infectious Kaposi's Sarcoma Herpesvirus-Containing Supernatant J. Virol., November 1, 2000; 74(21): 10187 - 10193. [Abstract] [Full Text] |
||||
![]() |
A. Krithivas, D. B. Young, G. Liao, D. Greene, and S. D. Hayward Human Herpesvirus 8 LANA Interacts with Proteins of the mSin3 Corepressor Complex and Negatively Regulates Epstein-Barr Virus Gene Expression in Dually Infected PEL Cells J. Virol., October 15, 2000; 74(20): 9637 - 9645. [Abstract] [Full Text] |
||||
![]() |
S. A. Keller, E. J. Schattner, and E. Cesarman Inhibition of NF-kappa B induces apoptosis of KSHV-infected primary effusion lymphoma cells Blood, October 1, 2000; 96(7): 2537 - 2542. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Schwam, R. L. Luciano, S. S. Mahajan, L. Wong, and A. C. Wilson Carboxy Terminus of Human Herpesvirus 8 Latency-Associated Nuclear Antigen Mediates Dimerization, Transcriptional Repression, and Targeting to Nuclear Bodies J. Virol., September 15, 2000; 74(18): 8532 - 8540. [Abstract] [Full Text] |
||||
![]() |
F. Pica, A. Volpi, A. Serafino, M. Fraschetti, O. Franzese, and E. Garaci Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8-infected primary effusion lymphoma cells Blood, May 1, 2000; 95(9): 2905 - 2912. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Szekely, C. Kiss, K. Mattsson, E. Kashuba, K. Pokrovskaja, A. Juhasz, P. Holmvall, and G. Klein Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies J. Gen. Virol., November 1, 1999; 80(11): 2889 - 2900. [Abstract] [Full Text] |
||||
![]() |
K. D. Jones, Y. Aoki, Y. Chang, P. S. Moore, R. Yarchoan, and G. Tosato Involvement of Interleukin-10 (IL-10) and Viral IL-6 in the Spontaneous Growth of Kaposi's Sarcoma Herpesvirus-Associated Infected Primary Effusion Lymphoma Cells Blood, October 15, 1999; 94(8): 2871 - 2879. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kellam, D. Bourboulia, N. Dupin, C. Shotton, C. Fisher, S. Talbot, C. Boshoff, and R. A. Weiss Characterization of Monoclonal Antibodies Raised against the Latent Nuclear Antigen of Human Herpesvirus 8 J. Virol., June 1, 1999; 73(6): 5149 - 5155. [Abstract] [Full Text] |
||||
![]() |
M. E. Ballestas, P. A. Chatis, and K. M. Kaye Efficient Persistence of Extrachromosomal KSHV DNA Mediated by Latency-Associated Nuclear Antigen Science, April 23, 1999; 284(5414): 641 - 644. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |